Clinical trial
Serological Screen and Treat Trial for P. Vivax: a Proof-of-concept Trial in Western Indonesia
NCT04223674 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serological Screen and Treat Trial for P. Vivax: a Proof-of-concept Trial in Western Indonesia
- Lead sponsor
- Indonesia University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 9, 2022
- Completion date
- December 30, 2023
- Enrollment
- 1,133 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.